Granuloma correlates of protection against tuberculosis and mechanisms of immune modulation by Mycobacterium tuberculosis

Journal of Infectious Diseases

Volumn 207, Issue 7, 2013, Pages 1115-1127

  Mehra, Smriti ^a   Alvarez, Xavier ^a   Didier, Peter J ^a   Doyle, Lara A ^a   Blanchard, James L ^a   Lackner, Andrew A ^a,b   Kaushal, Deepak ^a,b  

^a TULANE NATIONAL PRIMATE RESEARCH CENTER   (United States)

^b TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

IDO; Mycobacterium tuberculosis; transcriptomics

Indexed keywords

BCG VACCINE; CXCL1 CHEMOKINE; CXCL14 CHEMOKINE; CXCL16 CHEMOKINE; CXCL3 CHEMOKINE; CXCL9 CHEMOKINE; EOTAXIN; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE CHEMOTACTIC PROTEIN 2; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 4; SECONDARY LYMPHOID TISSUE CHEMOKINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL GENE; CCL13 GENE; CCL19 GENE; CCL2 GENE; CCL20 GENE; CCL4 GENE; CCR1 GENE; CCR2 GENE; CCR5 GENE; CCR7 GENE; CORRELATION ANALYSIS; CXCL1 GENE; CXCL10 GENE; CXCL11 GENE; CXCL13 GENE; CXCL16 GENE; CXCL3 GENE; CXCL6 GENE; CXCL9 GENE; DRUG EFFICACY; GRANULOMA; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOPATHOLOGY; INFECTION PREVENTION; MACACA; MACROPHAGE; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTOMICS; TREATMENT OUTCOME; TUBERCULOSIS; VACCINATION;

ANIMALS; BACTERIAL LOAD; BCG VACCINE; CHEMOKINES, CC; CHEMOKINES, CXC; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GRANULOMA; IMMUNOMODULATION; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; LUNG; MACACA FASCICULARIS; MACROPHAGES; MYCOBACTERIUM TUBERCULOSIS; NECROSIS; NEUTROPHILS; TIME FACTORS; TRANSCRIPTOME; TUBERCULOSIS, PULMONARY; VACCINATION;

EID: 84874731468     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jis778     Document Type: Article

References (48)

1. Dye C. Global epidemiology of tuberculosis. Lancet 2006; 367:938-40.
2. Orme IM. Prospects for new vaccines against tuberculosis. Trends Microbiol 1995; 3:401-4.
3. Orme IM. The Achilles heel of BCG. Tuberculosis 2010; 90:329-32.
4. Russell DG. Who puts the tubercle in tuberculosis? Nat Rev Microbiol 2007; 5:39-47. (Pubitemid 44942302)
5. Paige C, Bishai WR. Penitentiary or penthouse condo: the tuberculous granuloma from the microbe's point of view. Cell Microbiol 2010; 12:301-9.
6. Kaushal D, Mehra S, Didier PJ, Lackner AA. The nonhuman primate model of tuberculosis. J Med Primatol 2012; 41:191-201.
7. Kaushal D, Mehra S. Faithful experimental models of human Mycobacterium tuberculosis infections. Mycobacterial Dis 2012; 2:1.
8. Mehra S, Pahar B, Dutta NK, et al. Transcriptional reprogramming in nonhuman primate (rhesus macaque) tuberculosis granulomas. PLoS One 2010; 5:e12266.
9. Verreck FA, Vervenne RA, Kondova I, et al. MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques. PLoS One 2009; 4: e5264.
10. Larsen MH, Bierman K, Chen B, et al. Efficacy and safety of live attenuated persistent and rapidly cleared Mycobacterium tuberculosis vaccine candidates in non-human primates. Vaccine 2009; 27:4709-17.
11. Gormus BJ, Blanchard JL, Alvarez XH, Didier PJ. Evidence for a rhesus monkey model of asymptomatic tuberculosis. J Med Primatol 2004; 33:134-45. (Pubitemid 38618086)
12. Dutta NK, Mehra S, Didier PJ, et al. Genetic requirements for the survival of tubercle bacilli in primates. J Infect Dis 2010; 201:1743-52.
13. Mehra S, Golden NA, Dutta NK, et al. Reactivation of latent tuberculosis in rhesus macaques by co-infection with simian immunodeficiency virus. J Med Primatol 2011; 40:233-43.
14. Mehra S, Golden NA, Stuckey KJ, et al. The Mycobacterium tuberculosis SigH is required for bacterial burden as well as immunopathology in primates. J Infect Dis 2012; 205:1203-13.
15. Dutta NK, Mehra S, Martinez AN, et al. The stress-response factor SigH modulates the interaction between Mycobacterium tuberculosis and host phagocytes. PLoS One 2012; 7:e28958.
16. Kaushal D, Naeve CW. Analyzing and visualizing expression data with Spotfire. Curr Prot Bioinform 2004; chapter 7, unit 7.9.
17. Schroder JM, Mrowietz U, Christophers E. Purification and partial biologic characterization of a human lymphocyte derived peptide with potent neutrophil-stimulating activity. J Immunol 1988; 140:3534-40.
18. Huang S, Paulauskis JD, Godleski JJ, Kobzik L. Expression of macrophage inflammatory protein-2 and KC mRNA in pulmonary inflammation. Am J Pathol 1992; 141:981-8.
19. Nakagawa H, Komorita N, Shibata F, et al. Identification of cytokineinduced neutrophil chemoattractants (CINC), rat GRO/CINC-2 alpha and CINC-2 beta, produced by granulation tissue in culture: purification, complete amino acid sequences and characterization. Biochem J 1994; 301:545-50.
20. Schmal H, Shanley TP, Jones ML, Friedl HP, Ward PA. Role for macrophage inflammatory protein-2 in lipopolysaccharide-induced lung injury in rats. J Immunol 1996; 156:1963-72. (Pubitemid 26069332)
21. Wuyts A, Van Osselaer N, Haelens A, et al. Characterization of synthetic human granulocyte chemotactic protein 2: usage of chemokine receptors CXCR1 and CXCR2 and in vivo inflammatory properties. Biochemistry 1997; 36: 2716-23. (Pubitemid 27106667)
22. Schall TJ. Biology of the RANTES/SIS cytokine family. Cytokine 1991; 3:165-83.
23. Blanpain C, Migeotte I, Lee B, et al. CCR5 binds multiple CC-chemokines: MCP-3 acts as a natural antagonist. Blood 1999; 94:1899-905. (Pubitemid 29430405)
24. Reif K, Ekland EH, Ohl L, et al. Balanced responsiveness to chemoattractants from adjacent zones determines B-cell position. Nature 2002; 416:94-9. (Pubitemid 34215407)
25. Weninger W, von Andrian UH. Chemokine regulation of naïve T cell traffic in health and disease. Semin Immunol 2003; 15:257-70. (Pubitemid 38156054)
26. DeJesus CE, Egen J, Metzger M, et al. Transient neutropenia after granulocyte-colony stimulating factor administration is associated with neutrophil accumulation in pulmonary vasculature. Exp Hematol 2011; 39:142-50.
27. Eum SY, Kong JH, Hong MS, et al. Neutrophils are the predominant infected phagocytic cells in the airways of patients with active pulmonary TB. Chest 2010; 137:122-8.
28. Eruslanov EB, Lyadova IV, Kondratieva TK, et al. Neutrophil responses to Mycobacterium tuberculosis infection in genetically susceptible and resistant mice. Infect Immun 2005; 73:1744-53. (Pubitemid 40470763)
29. Blumenthal A, Nagalingam G, Huch JH, et al. M. tuberculosis induces potent activation of IDO-1, but this is not essential for the immunological control of infection. PLoS One 2012; 7:e37314.
30. Schmid M, Lehmann MJ, Lucius R, Gupta N. The apicomplexan parasite, Eimeria falciformis, co-opts host tryptophan catabolism for life cycle progression in the mouse. J Biol Chem 2012; 287:20197-207.
31. Popov A, Abdullah Z, Wickenhauser C, et al. Indoleamine 2,3-dioxygenase- expressing dendritic cells form suppurative granulomas following Listeria monocytogenes infection. J Clin Invest 2006; 116: 3160-70. (Pubitemid 44878630)
32. Via LE, Lin PL, Ray SM, et al. Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates. Infect Immun 2008; 76:2333-2340.
33. Kaufmann SH, Cole ST, Mizrahi V, Rubin E, Nathan C. Mycobacterium tuberculosis and the host response. J Exp Med 2005; 201:1693-97. (Pubitemid 41002887)
34. Kondratieva E, Logunova N, Majorov K, Averbakh M, Apt A. Host genetics in granuloma formation: human-like lung pathology in mice with reciprocal genetic susceptibility to M. tuberculosis and M. avium. PLoS One 2010; 5:e10515.
35. Love DM, Redford PS, Wilkinson RJ, O'Garra A, Martineau AR. Neutrophils in tuberculosis: friend or foe? Trends Immunol 2012; 33:14-25.
36. Kondratieva TK, Rubakova EI, Linge IA, Evstifeev VV, Majorov KB, Apt AS. B cells delay neutrophil migration toward the site of stimulus: tardiness critical for effective bacillus Calmette-Guérin vaccination against tuberculosis infection in mice. J Immunol 2010; 184: 1227-34.
37. Sawant KV, Cho H, Lyons M, Ly LH, McMurray DN. Guinea pig neutrophil- macrophage interactions during infection with Mycobacterium tuberculosis. Microbes Infect 2010; 12:828-37.
38. Duarte TA, Noronha-Dutra AA, Nery JS, et al. Mycobacterium tuberculosis- induced neutrophil ectosomes decrease macrophage activation. Tuberculosis (Edinb) 2012; 92:218-25.
39. Taylor MW, Feng GS. Relationship between interferon-gamma, indoleamine 2,3-dioxygenase, and tryptophan catabolism. FASEB J 1991; 5:2516-22. (Pubitemid 21905800)
40. Pffefferkorn ER. Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan. Proc Natl Acad Sci U S A 1984; 81:908-12.
41. Thomas SM, Garrity LF, Brandt CR, et al. IFN-gamma-mediated antimicrobial response. Indoleamine 2,3-dioxygenase-deficient mutant host cells no longer inhibit intracellular Chlamydia spp. or Toxoplasma growth. J Immunol 1993; 150:5529-34. (Pubitemid 23180667)
42. Loughman JA, Hunstad DA. Induction of indoleamine 2,3-dioxygenase by uropathogenic bacteria attenuates innate responses to epithelial infection. J Infect Dis 2012; 205:1830-9.
43. Mellor AL, Munn DH. IDO expression by dendritic cells: tolerance and tryptophan catabolism. Nat Rev Immunol 2004; 4:762-74. (Pubitemid 39336293)
44. von Bergwelt-Baildon MS, Popov A, Saric T, et al. CD25 and indoleamine 2,3-dioxygenase are up-regulated by prostaglandin E2 and expressed by tumor-associated dendritic cells in vivo: additional mechanisms of T-cell inhibition. Blood 2006; 108:228-37. (Pubitemid 43990633)
45. Terness P, Bauer TM, Röse L, et al. Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites. J Exp Med 2002; 196:447-57.
46. Munn DH, Sharma MD, Lee JR, et al. Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase. Science 2002; 297:1867-70. (Pubitemid 35024345)
47. Zganiacz A, Santosuosso M, Wang J, et al. TNF-alpha is a critical negative regulator of type 1 immune activation during intracellular bacterial infection. J Clin Invest 2004; 113:401-13. (Pubitemid 38544184)
48. Harper J, Skerry C, Davis SL, et al. Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions. J Infect Dis 2012; 205: 595-602.